CVS Health (1CVS) Stock Price & Analysis

1CVS Stock Chart & Stats

€81.28€0.28(0.35%)

At close: Oct 30 5:30 PM GMT+1

Day’s Range: EUR 80.96 - EUR 81.60
52-Week Range: EUR 33.00 - EUR 140.00
Previous Close: EUR 81.00
Volume: 0
Average Volume (3M): 21
Market Cap: EUR 103.35B
Enterprise Value: EUR 195.69B
Total Cash (Recent Filing): EUR 13.96B
Total Debt (Recent Filing): EUR 76.31B
Price to Earnings (P/E): 23.6
Beta: 0.09
Next Earnings: Nov 04, 2026 (Est.)
EPS Estimate: 1.48
Next Dividend Ex-Date: N/A
Dividend Yield: 2.91%

Bulls Say, Bears Say

Bulls Say

Cash Generation And Deleveraging

Strong and improving cash generation gives CVS greater capacity to fund operations, reduce debt, and invest in healthcare capabilities. The concurrent deleveraging trend improves financial flexibility and provides a more durable foundation for managing reimbursement or utilization pressure.

Health Services Growth

Caremark and related Health Services operations are showing meaningful revenue and profit growth, supported by purchasing economics, pharmacy mix, and specialty performance. Continued scale in these services can strengthen CVS’s integrated platform and support earnings resilience.

Specialty Pharmacy Advantage

Consistently higher adherence indicates a meaningful operational and technology advantage in specialty pharmacy, where outcomes and therapy persistence are important. This capability can support client retention, improve patient results, and reinforce CVS’s position in a structurally growing care category.

Bears Say

Compressed Profitability

Very thin and reduced margins leave CVS with limited earnings cushion when medical costs, reimbursement, or operating expenses increase. Although revenue remains large, weaker profitability and depressed returns indicate that scale is not currently translating into consistently strong economic efficiency.

340B Program Pressure

Ongoing 340B pressure can weigh on pharmacy economics beyond a single quarter because the program environment and manufacturer restrictions affect how related services are priced and reimbursed. The unresolved headwind could limit margin recovery and complicate forward earnings planning.

Caremark Membership Decline

Lower Caremark membership could reduce the scale supporting CVS’s purchasing, claims-processing, and benefit-management economics. Even disciplined client selection may create a period of revenue and volume pressure, while product exits and weaker retention make future growth less predictable.

CVS Health News

Options Volatility and Implied Earnings Moves This Week, November 02 – November 06, 2026

This week, several major companies will be reporting earnings. Among them are Apple (AAPL), Palantir Technologies (PLTR), Advanced Micro Devices (AMD), Pfizer (PFE), Super Micro Computer (SMCI). Ahead of this

1h agoO ET

CVS Health Corp (CVS) Q3 Earnings Cheat Sheet

CVS Health Corp (CVS) is scheduled to report 3rd quarter earnings on 11/04/2026, before the market opens. Regarding Q3 estimates, Wall Street analysts expect CVS Health Corp to post earnings

4h agoCVS 0HRS

The Week That Was, The Week Ahead: Macro and Markets, November 1

U.S. stocks ended Friday sharply lower as disappointing technology earnings and concerns over massive AI spending sent Wall Street into another sell-off. The Dow Jones Industrial Average (DJIA) fell 1.09%

1d agoC O

Private Markets: Claude developer Anthropic files to go public

Anthropic has publicly filed for a Nasdaq IPO, with the Claude developer widely expected to debut in mid-November at a valuation that could top $2 trillion. Meanwhile, cloud and AI

3d agoAI DE

Alaska Air appoints Amaresh Siva as chief information technology officer

Alaska Airlines (ALK) announced that Amaresh Siva has been named Chief Information Technology Officer. Siva will begin next month and will report directly to CEO Ben Minicucci. He will also

1w agoALK CVS

The Week That Was, The Week Ahead: Macro and Markets, October 18

U.S. stocks finished Friday sharply lower as a broad selloff in AI and technology shares dragged the Nasdaq to its worst week since June. The Dow Jones Industrial Average (DJIA)

2w agoT CL

Aetna deems IB-Stim by NeurAxis medically necessary

CVS Health’s (CVS) Aetna in a clinical policy bulletin announced that it considers percutaneous electrical nerve field stimulation with IB-Stim medically necessary durable medical equipment for the treatment of functional

2w agoCVS NRXS

CVS pays $315M to resolve allegations around opioid prescriptions

CVS Pharmacy has agreed to pay $315M to resolve allegations that, from October 17, 2013 through December 2, 2025, the company illegally filled prescriptions for opioids and other controlled substances

2w agoCVS 0HRS

CVS’s Aetna announces 69% of MA members are in ’27 plans rated 4 stars, up

Aetna, a CVS Health (CVS) company, announced that more than 69% of its Medicare Advantage, MA, members are in 2027 plans rated 4 stars or higher by the Centers for

2w agoCVS 0HRS

CVS Health price target lowered to $112 from $119 at Leerink

Leerink lowered the firm’s price target on CVS Health (CVS) to $112 from $119 and keeps an Outperform rating on the shares. The firm says CVS’ setup for Q3 looks

3w agoCVS 0HRS

UnitedHealth Stock (UNH): Piper Sandler Says ‘Buy’ Ahead of Q3 Earnings, While TD Cowen Cuts Price Target

UnitedHealth ($UNH) is scheduled to announce its third-quarter earnings on October 13. Ahead of Q3 earnings, Piper Sandler analyst Jessica Tassan reiterated a Buy rating on UNH stock after Centers

3w agoCVS HUM

CVS Star ratings came in weaker than expected for 2027, says TD Cowen

TD Cowen analyst Charles Rhyee says CVS Health’s (CVS) Star ratings came in weaker than expected for 2027, with 70% of MA enrollment in 4-star rated plans, down from 82%

3w agoCVS 0HRS

Humana price target raised to $475 from $405 at Oppenheimer

Oppenheimer raised the firm’s price target on Humana (HUM) to $475 from $405 and keeps an Outperform rating on the shares. Humana was the “biggest winner” from the Centers for

3w agoCNC CVS

Closing Bell Movers: Telecom stocks fall on SpaceX spectrum license

S&P 500 slipped for the second consecutive day while losses on the tech-dominant Nasdaq Composite accelerated, with the index finishing lower by 1.3% on Thursday. Technology was by far the

3w agoT CI

1CVS FAQ

What was CVS Health’s price range in the past 12 months?

CVS Health lowest stock price was €33.00 and its highest was €140.00 in the past 12 months.

What is CVS Health’s market cap?

CVS Health’s market cap is €103.35B.

When is CVS Health’s upcoming earnings report date?

CVS Health’s next earnings report is estimated for Nov 04, 2026 (not yet confirmed), which is in 2 days.

How were CVS Health’s earnings last quarter?

CVS Health released its earnings results on Aug 05, 2026. The company reported €2.31 earnings per share for the quarter, beating the consensus estimate of €1.66 by €0.65.

Is CVS Health overvalued?

According to Wall Street analysts CVS Health’s price is currently Undervalued.

Does CVS Health pay dividends?

CVS Health does not currently pay dividends.

What is CVS Health’s EPS estimate?

CVS Health’s EPS estimate is 1.48.

How many shares outstanding does CVS Health have?

CVS Health has 1,278,970,300 shares outstanding.

What happened to CVS Health’s price movement after its last earnings report?

CVS Health reported an EPS of €2.31 in its last earnings report, beating expectations of €1.66. Following the earnings report the stock price went down -6.196%.

Which hedge fund is a major shareholder of CVS Health?

Hedge funds hold CVS Health shares: the largest hedge-fund position in CVS Health is 722,069,113 shares, and hedge funds decreased their holdings by 18.9M shares last quarter.

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

CVS Health Stock Smart Score

Neutral

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

CVS Health

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health (1CVS) Earnings & Revenues

Historic Earnings Reports

1CVS Company Deck

1CVS Earnings Call

Q2 2026

0:00 / 0:00

Earnings Call SentimentPositive

The call conveyed strong operational and financial momentum across segments with material upside: double-digit growth in operating income, raised EPS guidance, improved cash flow outlook, specialty leadership, and early tangible AI-driven efficiencies. Offsetting these positives are notable industry-specific headwinds—most prominently near-term 340B pressures, anticipated Caremark membership declines in 2027, ongoing reimbursement and regulatory pressures, and some timing-related pull-forwards. Management emphasized disciplined execution, balance sheet improvement and a multi-year growth outlook (mid-teens EPS CAGR through 2028), while acknowledging and preparing for specific near-term headwinds.

View all IT:1CVS earnings summaries

1CVS Net sales Breakdown

46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other

1CVS Stock 12 Month Forecast

Average Price Target

EUR 102.93▲(26.63% Upside)

Past 12 Months12 Month ForecastJan2026Oct2026

HighEUR 112.37

AverageEUR 102.93

LowEUR 96.18

Detailed Analyst Forecast >

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	10	5	7
Technical Analysis	3	5	2
Moving Averages	7	0	5

Technical Analysis >

Similar Stocks

Stocks similar to IT:1CVS
Company	Price & Change	Follow
CNCCentene
CICigna
HUMHumana
UNHUnitedHealth
ELVElevance Health

Compare IT:1CVS Stocks >

Ownership Overview

0.41% Insiders
32.88% Mutual Funds
3.67% Other Institutional Investors
39.97% Public Companies and Individual Investors

Detailed Ownership Overview >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft